Depreciation Amortization - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Depreciation & Amortization Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Depreciation & Amortization
-ÂŁ61m
CAGR 3-Years
13%
CAGR 5-Years
-1%
CAGR 10-Years
4%
A
AstraZeneca PLC
NASDAQ:AZN
Depreciation & Amortization
-$3.8B
CAGR 3-Years
-27%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Depreciation & Amortization
-$90m
CAGR 3-Years
-22%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Allergy Therapeutics PLC
LSE:AGY
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Depreciation & Amortization
-ÂŁ140.2m
CAGR 3-Years
-26%
CAGR 5-Years
-21%
CAGR 10-Years
N/A

See Also

What is GlaxoSmithKline PLC's Depreciation & Amortization?
Depreciation & Amortization
-61m GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Depreciation & Amortization amounts to -61m GBP.

What is GlaxoSmithKline PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
4%

Over the last year, the Depreciation & Amortization growth was 24%. The average annual Depreciation & Amortization growth rates for GlaxoSmithKline PLC have been 13% over the past three years , -1% over the past five years , and 4% over the past ten years .

Back to Top